Cobra Biologics

Cobra Biologics, Vaccibody to manufacture DNA vaccine

Wednesday, May 15, 2013

Cobra Biologics, an international clinical and commercial manufacturer of biologics and pharmaceuticals, and Vaccibody, a biotechnology company developing the next generation of vaccines against cancer and chronic infections, have signed an agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies, such as precancerous lesions found in cervical cancer.

[Read More]